secwatch.observer — SEC 8-K summary
======================================

Issuer:     Intelligent Medicine Acquisition Corp. (—)
CIK:        0001850051
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001104659-23-017381
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IQMD shareholders approve extension to Sep 9, 2023; 20M shares redeemed for ~$207M
--------------------------------------------------------------------------------

- Extension approved: deadline to close business combination moved from Feb 9 to Sep 9, 2023.
- Holders of 20,009,861 public shares exercised redemption rights at ~$10.34/share, totaling ~$206.9M.
- Sponsor contributed 200,000 Class B shares to trust; will own 80.1% of outstanding Class A (if converted).
- Proposals 1 & 2 passed with ~78.7% of votes cast in favor; Adjournment Proposal not voted.
- Sponsor also holds private warrants for 9,245,000 Class A shares, currently not exercisable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850051/000110465923017381/0001104659-23-017381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850051/000110465923017381/tm236108d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-017381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer